Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine

References

• Schmid P, Rauber D, Betsch C, et al. Barriers of influenza vaccination intention and behavior—a systematic review of influenza vaccine hesitancy, 2005–2016. PLoS One 2017;12(1):e0170550. doi: 10.1371/journal.pone.0170550
   PubMed Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–1300. doi: 10.1016/S0140-6736(17)33293-2
   PubMed Web of Science ®Google Scholar
• Langer J, Welch VL, Moran MM, et al. High clinical burden of influenza disease in adults aged ≥ 65 years: can we do better? A systematic literature review. Adv Ther 2023;40(4):1601–1627. doi: 10.1007/s12325-023-02432-1
   PubMedGoogle Scholar
• Tokars JI, Olsen SJ, Reed C. Seasonal incidence of symptomatic influenza in the United States. Clin Infect Dis. 2018;66(10):1511–8. doi: 10.1093/cid/cix1060
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States—2018–2019 flu season; 2021 Sep 29 [cited 2023 Oct 25]. Available from: https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/about/burden/2018-2019.html
   Google Scholar
• de Courville C, Cadarette SM, Wissinger E, et al. The economic burden of influenza among adults aged 18 to 64: a systematic literature review. Influenza Other Respir Viruses 2022;16(3):376–385. doi: 10.1111/irv.12963
   PubMed Web of Science ®Google Scholar
• World Health Organization. Vaccines against influenza: WHO position paper—May 2022. Wkly Epidemiol Rec 2022;97(19):185–208.
   Google Scholar
• McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis 2015;211(10):1529–1540. doi: 10.1093/infdis/jiu647
   PubMed Web of Science ®Google Scholar
• Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013–2014 in the United States. J Infect Dis. 2016;213(10):1546–1556. doi: 10.1093/infdis/jiv577
   PubMed Web of Science ®Google Scholar
• Flannery B, Kondor RJG, Chung JR, et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018–2019 season. J Infect Dis. 2020;221(1):8–15. doi: 10.1093/infdis/jiz543
   PubMed Web of Science ®Google Scholar
• Tenforde MW, Kondor RJG, Chung JR, et al. Effect of antigenic drift on influenza vaccine effectiveness in the United States–2019–2020. Clin Infect Dis 2021;73(11):e4244–e50. doi: 10.1093/cid/ciaa1884
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. How influenza (flu) vaccines are made; [updated 2022 Nov 3;cited 2023 Oct 25]. Available from: https://www.cdc.gov/flu/prevent/how-fluvaccine-made.htm
   Google Scholar
• Rockman S, Laurie K, Ong C, et al. Cell-based manufacturing technology increases antigenic match of influenza vaccine and results in improved effectiveness. Vaccines (Basel). 2022;11(1):52. doi: 10.3390/vaccines11010052
   PubMed Web of Science ®Google Scholar
• Puig-Barberà J, Tamames-Gómez S, Plans-Rubio P, et al. Relative effectiveness of cell-cultured versus egg-based seasonal influenza vaccines in preventing influenza-related outcomes in subjects 18 years old or older: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(2):818. doi: 10.3390/ijerph19020818
   PubMed Web of Science ®Google Scholar
• Tokars JI, Rolfes MA, Foppa IM, et al. An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States. Vaccine. 2018;36(48):7331–7337. doi: 10.1016/j.vaccine.2018.10.026
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2022–23 influenza season. MMWR Recomm Rep. 2022;71(1):1–28. doi: 10.15585/mmwr.rr7101a1
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Seasonal influenza vaccine effectiveness, 2017–2018; [updated 2019 Feb 25;cited 2023 Jun 27]. Available from: https://www.cdc.gov/flu/vaccines-work/2017-2018.html
   Google Scholar
• Centers for Disease Control [Internet]. Atlanta (GA): CDC; c1946–2023. US flu VE data for 2018–2019; [updated 2019 Nov 6;cited 2023 Jun 27]. Available from: https://www.cdc.gov/flu/vaccines-work/2018-2019.html.
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. US flu VE data for 2019-2020; [updated 2020 Dec 22;cited 2023 Jun 26]. Available from: https://www.cdc.gov/flu/vaccines-work/2019–2020.html
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Weekly flu vaccination dashboard. [cited 2023 Jun 26]. Available from: https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-dashboard.html
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Influenza hospitalization surveillance network (FluSurv-NET). [cited 2023 Jun 26]. Available from: https://www.cdc.gov/flu/weekly/influenza-hospitalization-surveillance.htm.
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. How CDC estimates the burden of seasonal influenza in the U.S. [updated 2019 Nov 22;cited 2023 Oct 25]. Available from: https://www.cdc.gov/flu/about/burden/how-cdc-estimates.htm
   Google Scholar
• U. S. Census Bureau [Internet]. Washington (DC): U.S. Census Bureau; c1902–2023. 2019 Annual social and economic supplements; [updated 2021 Oct 8;cited 2023 Oct 25]. Available from: https://www.census.gov/data/datasets/2019/demo/cps/cps-asec-2019.html
   Google Scholar
• Boikos C, McGovern I, Molrine D, et al. Review of analyses estimating relative vaccine effectiveness of cell-based quadrivalent influenza vaccine in three consecutive US influenza seasons. Vaccines (Basel). 2022;10(6):896. doi: 10.3390/vaccines10060896
   PubMed Web of Science ®Google Scholar
• Boikos C, Sylvester GC, Sampalis JS, et al. Relative effectiveness of the cell-cultured quadrivalent influenza vaccine compared to standard, egg-derived quadrivalent influenza vaccines in preventing influenza-like illness in 2017–2018. Clin Infect Dis. 2020;71(10):e665–71. doi: 10.1093/cid/ciaa371
   PubMed Web of Science ®Google Scholar
• Boikos C, Fischer L, O’Brien D, et al. Relative effectiveness of the cell-derived inactivated quadrivalent influenza vaccine versus egg-derived inactivated quadrivalent influenza vaccines in preventing influenza-related medical encounters during the 2018–2019 influenza season in the United States. Clin Infect Dis 2021;73(3):e692–8. doi: 10.1093/cid/ciaa1944
   PubMed Web of Science ®Google Scholar
• Imran M, Ortiz JR, McLean HQ, et al. Relative effectiveness of cell-based versus egg-based quadrivalent influenza vaccines in adults during the 2019–2020 influenza season in the United States. Open Forum Infect Dis 2022;9(10):ofac532. doi: 10.1093/ofid/ofac532
   PubMed Web of Science ®Google Scholar
• Lewis NM, Chung JR, Uyeki TM, et al. Interpretation of relative efficacy and effectiveness for influenza vaccines. Clin Infect Dis. 2022;75(1):170–175. doi: 10.1093/cid/ciab1016
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Archived: estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States—2017–2018 influenza season. [cited 2023 Jun 27]. Available from: https://www.cdc.gov/flu/about/burden/2017-2018/archive.htm
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Archived: estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States—2018–2019 influenza season. [cited 2023 Jun 27]. Available from: https://www.cdc.gov/flu/about/burden/2018-2019/archive-09292021.html
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Archived: estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States—2019–2020 influenza season. [cited 2023 Jun 27]. Available from: https://www.cdc.gov/flu/about/burden/2019-2020/archive-09292021.html
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States—2017–2018 flu season; 2021 Sep 30 [cited 2023 Oct 25]. Available from: https://archive.cdc.gov/#/details?url=https://www.cdc.gov/flu/about/burden/2017-2018.htm
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): CDC; c1946–2023. Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States—2019–2020 flu season. 2022 Oct 7 [cited 2023 Oct 25]. Available from: https://www.cdc.gov/flu/about/burden/2019-2020.html
   Google Scholar
• Coleman BL, Gutmanis I, McGovern I, et al. Effectiveness of cell-based quadrivalent seasonal influenza vaccine: a systematic review and meta-analysis. Vaccines (Basel). 2023;11(10):1607. doi: 10.3390/vaccines11101607
   PubMed Web of Science ®Google Scholar